Clinical trials
Transplant Recipient clinical trials
Below are recruiting transplant recipient clinical trials, each written for real people, not researchers. We’re tracking 174 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06997471RecruitingPhase 1
Safety of modified stem cell infusion with organ transplant
This early-phase trial tests whether it is safe to give a special type of stem cell transplant (with the naïve T cells removed and only memory T cells left) to people receiving organ transplants. It is for children getting intestine or lung transplants, and for children or adults getting kidney transplants.
Madrid, MadridAges birth+ - NCT07301853Recruiting
Long-term follow-up for liver transplant patients and living donors
This study follows liver transplant recipients and living donors over time to track their health outcomes. It aims to understand their recovery and long-term wellbeing.
Hangzhou, ZhejiangAges 18 years+ - NCT07143773RecruitingPhase 4
SGLT2i safety in kidney transplant patients without diabetes
This study tests whether a medicine called SGLT2i (a type of pill for kidney health) is safe and helpful for kidney transplant recipients who do not have diabetes. It aims to see if it can improve how the new kidney works.
OdenseAges 18 years+ - NCT06707792Recruiting
6-minute stepper test reliability in kidney transplant patients
This study checks if a 6-minute stepper test is a valid and reliable way to measure exercise ability in people who have had a kidney transplant. It helps doctors understand your fitness without needing complex equipment.
AnkaraAges 18–65 - NCT06806670Recruiting
Diet and exercise study for kidney transplant patients
This study tests whether a structured diet and exercise program can lower heart disease risk in kidney transplant recipients. If you've had a stable transplant for at least 6 months and up to 10 years, you may be able to join.
Bologna, BOAges 30–69 - NCT04128189RecruitingPhase 3
Shingrix vaccine for people waiting for a kidney transplant
This Phase 3 study tests whether the shingles vaccine Shingrix is safe and effective for adults with chronic kidney failure who are on the transplant waiting list. It aims to protect you from shingles while you may be dealing with transplant-related immune changes.
Aurora, ColoradoAges 18–70 - NCT05938712RecruitingPhase 2
Kidney transplant trial using two diabetes medicines safely
This Phase 2 trial tests whether combining two diabetes medicines—an SGLT2 tablet and a GLP-1 shot (semaglutide)—can improve kidney outcomes and safety in people with a kidney transplant. It may help some recipients, but it also carefully checks for infection risk, diabetes complications, and pregnancy plans.
Toronto, OntarioAges 18 years+ - NCT06751992RecruitingPhase 4
Thinking and memory with extended-release tacrolimus in kidney transplant
This study tests if switching to an extended-release form of your anti-rejection medication (tacrolimus) helps protect memory and thinking skills. It is for older adults who have had a kidney transplant at least one year ago.
Boston, MassachusettsAges 65 years+ - NCT07370727Recruiting
Weight training for kidney transplant patients
This trial studies whether a personalized weight training program helps kidney transplant recipients improve their strength and health. It is for people who are at least one year post-transplant and have stable kidney function.
Bogotá, Bogota D.C.Ages 18–50 - NCT07531966Recruiting
Blood Vessel Problems After Kidney Transplant Treatment
This study looks at treating narrowing or blockage of blood vessels in transplanted kidneys. If your transplanted kidney is showing signs of not working well and imaging shows a blocked vessel, this trial tests whether a procedure called angioplasty (opening the vessel with a tiny balloon) can help restore blood flow and improve kidney function.
AarhusAges 18 years+ - NCT07235683RecruitingPhase 4
Stronger CMV treatment for lung transplant recipients
This trial tests adding a drug called letermovir to standard antiviral therapy for lung transplant patients with CMV infection. The goal is to see if the combination helps clear the virus faster and more effectively.
Toronto, OntarioAges 18 years+ - NCT06190171Recruiting
Breathing strength training for heart transplant patients
This trial tests whether a special breathing and muscle-strengthening exercise program can help people waiting for a heart transplant. It is designed to improve your respiratory strength and overall conditioning before surgery.
Nashville, TennesseeAges 18–90 - NCT07532694Recruiting
Laser Treatment for Gum Disease in Kidney Transplant Patients
This study tests whether a special diode laser can safely and effectively treat gum disease (periodontitis) in people who have received a kidney transplant. Gum disease is common in transplant recipients and can affect overall health, so this treatment may help protect both oral and transplant health.
Hanoi, HadongAges Any age - NCT04954690Recruiting
Exercise program after kidney transplant for older adults
This trial tests a structured, coached exercise program for people who recently received a living-donor kidney and are coming from dialysis. It may help improve strength and daily function after transplant, especially if starting fitness is difficult.
San Francisco, CaliforniaAges 50 years+ - NCT06874920Enrolling by invitation
Antibiotic choice based on hospital lab reports in transplant patients with bloodstream infection
This study looks at whether choosing antibiotics based on local hospital lab reports (antibiograms) works well for organ transplant patients who have a single bacteria in their bloodstream. It hopes to find the best way to treat these infections.
MilanAges 18 years+ - NCT06025240Recruiting
Better antibody monitoring after kidney transplant
This study tests a new way to monitor harmful antibodies after a kidney transplant. It may help prevent transplant rejection over time.
Liverpool, MerseysideAges 18 years+ - NCT03665675RecruitingEarly Phase 1
Immune cell treatment to control CMV or adenovirus after transplant
This early-phase study tests donor immune cells made to recognize CMV (a virus) or adenovirus, given to help control virus reactivation after a solid organ or bone marrow transplant. It may help reduce ongoing or worsening viral infection when standard antiviral medicines are hard to tolerate or not working well.
Columbus, OhioAges 1–85 - NCT01062581Recruiting
Study of organ transplants done at University of Minnesota
This registry study collects information about people who received an organ transplant at the University of Minnesota and about living donors who donated there. It helps researchers learn from transplant experiences to improve care.
Minneapolis, MinnesotaAges Any age - NCT07305012Recruiting
Healthy lifestyle tool for older liver and kidney transplant recipients
This study tests a new tool designed to help people aged 60 or older who have received a liver or kidney transplant improve their eating and physical activity habits. It aims to see if the tool is easy to use and helpful for maintaining a healthy lifestyle.
Bologna, BOAges 60 years+ - NCT06950931Enrolling by invitation
Urine test for kidney problem after transplant or biopsy
This study tests whether a special urine test can detect kidney problems early in people who have had a kidney transplant or who have chronic or acute kidney disease. It requires a first-morning urine sample and regular check-ups at the study hospital.
Martin, SlovakiaAges 18 years+ - NCT05626530RecruitingPhase 4
Letermovir to prevent CMV after transplant illness
This trial studies whether letermovir can help prevent CMV (a common virus after transplant) from coming back after you’ve already been treated. If you qualify, you may be offered letermovir as “secondary prevention” and followed for about 6 months.
Boston, MassachusettsAges 18–75 - NCT06428097RecruitingPhase 1
Thyroid hormone before heart transplant
This study tests whether giving a thyroid hormone supplement called levothyroxine before a heart transplant can help with recovery. It is for people already listed for a heart transplant who do not have thyroid problems.
San Francisco, CaliforniaAges 18 years+ - NCT06474273RecruitingPhase 3
Treating T-cell rejection after kidney transplant
This trial tests a new approach to treat T-cell mediated rejection in kidney transplant recipients. It aims to safely and effectively stop the rejection episode.
Lambton, New South WalesAges 2 years+ - NCT07035743Recruiting
Lung response to exercise after double lung transplant
This study looks at how your lungs respond to exercise after a double lung transplant. It aims to understand normal recovery patterns and may help improve care for other transplant recipients.
TaoyuanAges 20 years+
Hear when a new Transplant Recipient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplant recipient?
- Yes. Clin2 currently lists 174 recruiting transplant recipient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplant recipient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplant recipient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.